MEHLMAN CONSULTING, INC. for VIZIENT INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Healthcare coverage; prescription drug costs; group purchasing issues; drug shortage issues. 340B Drug Pricing Program. S. 1895, No Surprises Act. S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136 H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act - Public Law No: 116-123 H.R. 6201, the Families First Coronavirus Response Act - Public Law No: 116-127 CARES Act Implementation and H.R. 266, Paycheck Protection Program and Health Care Enhancement Act and H.R. 6800, HEROES Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN ARONSON | — |
| DEAN ROSEN | — |
Medicare/Medicaid MMM
Healthcare transparency, costs and access to affordable medication and other healthcare items and services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN ROSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.